Spots Global Cancer Trial Database for Impact of Omega 3 Fatty Acid Supplementation on Aromatase in Obese Subjects
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Impact of Omega 3 Fatty Acid Supplementation on Aromatase in Obese Subjects
Official Title: A Phase 0, Investigator Initiated Study, Evaluating the Impact of Omega 3 Fatty Acid Supplementation on Aromatase in Obese Postmenopausal Women With Estrogen Receptor Positive Breast Cancer
Study ID: NCT02538484
Conditions
Study Description
Brief Summary: Assess the impact of dietary omega 3 free fatty acids and/or letrozole on obese, postmenopausal breast cancer patients.
Detailed Description: Prospective, comparative, three arm, short term, non-interventional study with correlative biomarker endpoints. Sixty (60) obese (≥ 30 BMI) newly diagnosed ER+ postmenopausal breast cancer patients will be recruited to participate in a short term (30 day) Phase 0 biomarker evaluation study prior to surgical resection.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Houston Methodist Cancer Center at Texas Medical Center, Houston, Texas, United States
Mays Cancer Center, UT Health San Antonio, San Antonio, Texas, United States
Contact Details
Name: Andrew Brenner, MD, PhD
Affiliation: Principal Investigator
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
